Sarah Lucia Thiel1, Myriam Carol Weber1, Lorenz Risch2, Nadia Wohlwend3, Thomas Lung4, Dorothea Hillmann4, Michael Ritzler4, Martin Risch5, Philipp Kohler6, Pietro Vernazza6, Christian R Kahlert7, Felix Fleisch8, Alexia Cusini8, Tomas V Karajan1, Sandra Copeland1, Matthias Paprotny1. 1. Department of General Internal Medicine, Landesspital Liechtenstein, Vaduz, Liechtenstein. 2. Labormedizinisches Zentrum Dr Risch, Vaduz, Liechtenstein / Centre of Laboratory Medicine, University Institute of Clinical Chemistry, University of Bern, Switzerland / Private University of the Principality of Liechtenstein, Triesen, Liechtenstein. 3. Private University of the Principality of Liechtenstein, Triesen, Liechtenstein. 4. Labormedizinisches Zentrum Dr Risch, Vaduz, Liechtenstein. 5. Central Laboratory, Kantonsspital Graubünden, Chur, Switzerland. 6. Division of Infectious Diseases and Hospital Epidemiology, Kantonsspital St Gallen, Switzerland. 7. Division of Infectious Diseases and Hospital Epidemiology, Kantonsspital St Gallen, Switzerland / Department of Infectious Diseases and Hospital Epidemiology, Children's Hospital of Eastern Switzerland, St Gallen, Switzerland. 8. Division of Infectious Diseases and Hospital Epidemiology, Kantonsspital Graubünden, Chur, Switzerland.
Abstract
BACKGROUND: The principality of Liechtenstein had its first COVID-19 case at the beginning of March 2020. After exponential growth, the pandemic’s first wave was contained, with the last case being diagnosed 52 days after the initial occurrence. AIM: To characterise the COVID-19 pandemic in Liechtenstein. METHODS: All patients diagnosed in Liechtenstein were followed up until recovery and again 6–8 weeks after symptom onset. They were contacted every 2 days to record their clinical status until the resolution of their symptoms. The diagnosis of COVID-19 was based on clinical symptoms and molecular testing. Household and close workplace contacts were included in the follow-up, which also comprised antibody testing. In addition, public health measures installed during the pandemic in Liechtenstein are summarised. RESULTS: During the first wave, 5% of the population obtained a reverse transcriptase polymerase chain reaction test. A total of 95 patients (median age 39 years) were diagnosed with COVID-19 (82 who resided in Liechtenstein), resulting in an incidence in Liechtenstein of 0.211%. One patient, aged 94, died (mortality rate 1%). Only 62% of patients could retrospectively identify a potential source of infection. Testing the patients’ household and close workplace contacts (n = 170) with antibody tests revealed that 25% of those tested were additional COVID-19 cases, a quarter of whom were asymptomatic. Those households which adhered to strict isolation measures had a significantly lower rate of affected household members than those who didn’t follow such measures. The national public health measures never restricted free movement of residents. Masks were only mandatory in healthcare settings. The use of home working for the general workforce was promoted. Gatherings were prohibited. Schools, universities, certain public spaces (like sports facilities and playgrounds), childcare facilities, nonessential shops, restaurants and bars were closed. Social distancing, hygienic measures, solidarity and supporting individuals who were at risk were the main pillars of the public health campaigns. CONCLUSION: The close collaboration of all relevant stakeholders allowed for the complete workup of all COVID-19 patients nationwide. A multitude of factors (e.g., young age of the patients, low-threshold access to testing, close monitoring of cases, high alertness and adherence to public health measures by the population) led to the early containment of the first wave of the pandemic, with a very low rate of serious outcomes. Antibody testing for SARS-CoV-2 revealed a substantial proportion of undiagnosed COVID-19 cases among close contacts of the patients.
BACKGROUND: The principality of Liechtenstein had its first COVID-19 case at the beginning of March 2020. After exponential growth, the pandemic’s first wave was contained, with the last case being diagnosed 52 days after the initial occurrence. AIM: To characterise the COVID-19 pandemic in Liechtenstein. METHODS: All patients diagnosed in Liechtenstein were followed up until recovery and again 6–8 weeks after symptom onset. They were contacted every 2 days to record their clinical status until the resolution of their symptoms. The diagnosis of COVID-19 was based on clinical symptoms and molecular testing. Household and close workplace contacts were included in the follow-up, which also comprised antibody testing. In addition, public health measures installed during the pandemic in Liechtenstein are summarised. RESULTS: During the first wave, 5% of the population obtained a reverse transcriptase polymerase chain reaction test. A total of 95 patients (median age 39 years) were diagnosed with COVID-19 (82 who resided in Liechtenstein), resulting in an incidence in Liechtenstein of 0.211%. One patient, aged 94, died (mortality rate 1%). Only 62% of patients could retrospectively identify a potential source of infection. Testing the patients’ household and close workplace contacts (n = 170) with antibody tests revealed that 25% of those tested were additional COVID-19 cases, a quarter of whom were asymptomatic. Those households which adhered to strict isolation measures had a significantly lower rate of affected household members than those who didn’t follow such measures. The national public health measures never restricted free movement of residents. Masks were only mandatory in healthcare settings. The use of home working for the general workforce was promoted. Gatherings were prohibited. Schools, universities, certain public spaces (like sports facilities and playgrounds), childcare facilities, nonessential shops, restaurants and bars were closed. Social distancing, hygienic measures, solidarity and supporting individuals who were at risk were the main pillars of the public health campaigns. CONCLUSION: The close collaboration of all relevant stakeholders allowed for the complete workup of all COVID-19patients nationwide. A multitude of factors (e.g., young age of the patients, low-threshold access to testing, close monitoring of cases, high alertness and adherence to public health measures by the population) led to the early containment of the first wave of the pandemic, with a very low rate of serious outcomes. Antibody testing for SARS-CoV-2 revealed a substantial proportion of undiagnosed COVID-19 cases among close contacts of the patients.
Authors: Martin Risch; Myriam Weber; Sarah Thiel; Kirsten Grossmann; Nadia Wohlwend; Thomas Lung; Dorothea Hillmann; Michael Ritzler; Francesca Ferrara; Susanna Bigler; Konrad Egli; Thomas Bodmer; Mauro Imperiali; Yacir Salimi; Felix Fleisch; Alexia Cusini; Harald Renz; Philipp Kohler; Pietro Vernazza; Christian R Kahlert; Matthias Paprotny; Lorenz Risch Journal: Biomed Res Int Date: 2020-11-16 Impact factor: 3.411
Authors: Martin Risch; Kirsten Grossmann; Diederick E Grobbee; Maureen Cronin; David Conen; Brianna M Goodale; Lorenz Risch; Stefanie Aeschbacher; Ornella C Weideli; Marc Kovac; Fiona Pereira; Nadia Wohlwend; Corina Risch; Dorothea Hillmann; Thomas Lung; Harald Renz; Raphael Twerenbold; Martina Rothenbühler; Daniel Leibovitz; Vladimir Kovacevic; Andjela Markovic; Paul Klaver; Timo B Brakenhoff; Billy Franks; Marianna Mitratza; George S Downward; Ariel Dowling; Santiago Montes Journal: BMJ Open Date: 2022-06-21 Impact factor: 3.006